MorphoSys Analyst Ratings
MorphoSys Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/21/2023 | 277.36% | JMP Securities | → $17 | Reiterates | Market Outperform → Market Outperform |
10/13/2023 | 104.22% | Morgan Stanley | $3.7 → $9.2 | Upgrades | Underweight → Overweight |
09/15/2023 | 105.33% | Goldman Sachs | $3.5 → $9.25 | Upgrades | Sell → Neutral |
06/22/2023 | 232.96% | JMP Securities | → $15 | Reiterates | Market Outperform → Market Outperform |
06/16/2023 | 277.36% | Wells Fargo | → $17 | Initiates Coverage On | → Overweight |
06/16/2023 | 121.98% | JP Morgan | $3.3 → $10 | Upgrades | Underweight → Overweight |
01/03/2023 | — | JP Morgan | Downgrades | Neutral → Underweight | |
11/18/2022 | 232.96% | JMP Securities | $32 → $15 | Maintains | Market Outperform |
01/14/2022 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
08/06/2021 | — | Deutsche Bank | Downgrades | Buy → Hold | |
06/11/2021 | 432.74% | JP Morgan | $32 → $24 | Downgrades | Overweight → Neutral |
06/03/2021 | — | Bryan Garnier | Downgrades | Buy → Neutral | |
06/03/2021 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
05/24/2021 | 521.53% | Morgan Stanley | → $28 | Upgrades | Equal-Weight → Overweight |
03/23/2021 | — | SVB Leerink | Downgrades | Outperform → Market Perform | |
11/25/2020 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
11/20/2019 | — | Guggenheim | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
11/21/2023 | 277.36% | JMP 证券 | → 17 美元 | 重申 | 市场跑赢大盘 → 市场跑赢大盘 |
10/13/2023 | 104.22% | 摩根士丹利 | 3.7 美元 → 9.2 美元 | 升级 | 体重过轻 → 超重 |
09/15/2023 | 105.33% | 高盛 | 3.5 美元 → 9.25 美元 | 升级 | 卖出 → 中立 |
06/22/2023 | 232.96% | JMP 证券 | → 15 美元 | 重申 | 市场跑赢大盘 → 市场跑赢大盘 |
06/16/2023 | 277.36% | 富国银行 | → 17 美元 | 启动覆盖范围开启 | → 超重 |
06/16/2023 | 121.98% | 摩根大通 | 3.3 美元 → 10 美元 | 升级 | 体重过轻 → 超重 |
01/03/2023 | — | 摩根大通 | 降级 | 中性 → 体重不足 | |
11/18/2022 | 232.96% | JMP 证券 | 32 美元 → 15 美元 | 维护 | 市场表现跑赢大盘 |
2022 年 1 月 14 日 | — | 摩根士丹利 | 降级 | 超重 → 重量相等 | |
2021 年 6 月 8 日 | — | 德意志银行 | 降级 | 买入 → 持有 | |
06/11/2021 | 432.74% | 摩根大通 | 32 美元 → 24 美元 | 降级 | 超重 → 中性 |
06/03/2021 | — | 布莱恩·卡尼尔 | 降级 | 买入 → 中性 | |
06/03/2021 | — | SVB Leerink | 升级 | 市场表现 → 跑赢大盘 | |
05/24/2021 | 521.53% | 摩根士丹利 | → 28 美元 | 升级 | 重量相等 → 超重 |
03/23/2021 | — | SVB Leerink | 降级 | 跑赢大盘 → 市场表现 | |
11/25/2020 | — | 摩根士丹利 | 启动覆盖范围开启 | → 重量相等 | |
2019 年 11 月 20 日 | — | 古根海姆 | 启动覆盖范围开启 | → 购买 |
What is the target price for MorphoSys (MOR)?
MorphoSys (MOR) 的目标价格是多少?
The latest price target for MorphoSys (NASDAQ: MOR) was reported by JMP Securities on November 21, 2023. The analyst firm set a price target for $17.00 expecting MOR to rise to within 12 months (a possible 277.36% upside). 7 analyst firms have reported ratings in the last year.
摩根大通证券于2023年11月21日公布了MorphoSys(纳斯达克股票代码:MOR)的最新目标股价。该分析公司将目标股价定为17.00美元,预计MOR将在12个月内升至12个月内(可能上涨277.36%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for MorphoSys (MOR)?
MorphoSys (MOR) 的最新分析师评级是多少?
The latest analyst rating for MorphoSys (NASDAQ: MOR) was provided by JMP Securities, and MorphoSys reiterated their market outperform rating.
MorphoSys(纳斯达克股票代码:MOR)的最新分析师评级由JMP Securities提供,MorphoSys重申了其市场跑赢大盘的评级。
When is the next analyst rating going to be posted or updated for MorphoSys (MOR)?
MorphoSys(MOR)的下一份分析师评级何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MorphoSys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MorphoSys was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与MorphoSys的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。MorphoSys的最新评级是在2023年11月21日公布的,因此您应该预计下一个评级将在2024年11月21日左右公布。
Is the Analyst Rating MorphoSys (MOR) correct?
分析师的评级 MorphoSys (MOR) 是否正确?
While ratings are subjective and will change, the latest MorphoSys (MOR) rating was a reiterated with a price target of $0.00 to $17.00. The current price MorphoSys (MOR) is trading at is $4.51, which is within the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的MorphoSys(MOR)评级得到了重申,目标股价为0.00美元至17.00美元。MorphoSys(MOR)目前的交易价格为4.51美元,在分析师的预测区间内。